AAAAAA

   
Results: 1-17 |
Results: 17
SELECTIVE-INHIBITION OF CELL-PROLIFERATION AND BCR-ABL PHOSPHORYLATION IN ACUTE LYMPHOBLASTIC-LEUKEMIA CELLS EXPRESSING M-R-190,000 BCR-ABLPROTEIN BY A TYROSINE KINASE INHIBITOR (CGP-57148)
Authors: BERAN M CAO XB ESTROV Z JEHA S JIN GZ OBRIEN S TALPAZ M ARLINGHAUS RB LYDON NB KANTARJIAN H
Citation: M. Beran et al., SELECTIVE-INHIBITION OF CELL-PROLIFERATION AND BCR-ABL PHOSPHORYLATION IN ACUTE LYMPHOBLASTIC-LEUKEMIA CELLS EXPRESSING M-R-190,000 BCR-ABLPROTEIN BY A TYROSINE KINASE INHIBITOR (CGP-57148), Clinical cancer research, 4(7), 1998, pp. 1661-1672
ACUTE REVERSIBLE ARTHROPATHY IN A PEDIATRIC-PATIENT WITH CANCER TREATED WITH A SHORT-COURSE OF CIPROFLOXACIN FOR FEBRILE NEUTROPENIA
Authors: MULLEN CA PETROPOULOS D RYTTING M JEHA S ZIPF T ROBERTS WM ROLSTON KV
Citation: Ca. Mullen et al., ACUTE REVERSIBLE ARTHROPATHY IN A PEDIATRIC-PATIENT WITH CANCER TREATED WITH A SHORT-COURSE OF CIPROFLOXACIN FOR FEBRILE NEUTROPENIA, Journal of pediatric hematology/oncology, 20(5), 1998, pp. 516-517
TALLIMUSTINE, AN EFFECTIVE ANTILEUKEMIC AGENT IN A SEVERE COMBINED IMMUNODEFICIENT MOUSE MODEL OF ADULT MYELOGENOUS LEUKEMIA, INDUCES REMISSIONS IN A PHASE-I STUDY
Authors: BERAN M JEHA S OBRIEN S ESTEY E VITEK L ZURLO MG RIOS MB KEATING M KANTARJIAN H
Citation: M. Beran et al., TALLIMUSTINE, AN EFFECTIVE ANTILEUKEMIC AGENT IN A SEVERE COMBINED IMMUNODEFICIENT MOUSE MODEL OF ADULT MYELOGENOUS LEUKEMIA, INDUCES REMISSIONS IN A PHASE-I STUDY, Clinical cancer research, 3(12), 1997, pp. 2377-2384
HIGH-DOSE MERCAPTOPURINE AND INTERMEDIATE-DOSE CYTARABINE DURING FIRST REMISSION OF ACUTE MYELOID-LEUKEMIA
Authors: CANPOLAT C JEHA S LOCKHART S RAMIREZ I ZIPF T PINKEL D
Citation: C. Canpolat et al., HIGH-DOSE MERCAPTOPURINE AND INTERMEDIATE-DOSE CYTARABINE DURING FIRST REMISSION OF ACUTE MYELOID-LEUKEMIA, Cancer investigation, 15(2), 1997, pp. 121-126
SELECTIVE-INHIBITION OF CELL-PROLIFERATION AND BCR-ABL PHOSPHORYLATION IN ACUTE LYMPHOBLASTIC-LEUKEMIA CELLS EXPRESSING 190-KD BCR-ABL PROTEIN BY A TYROSINE KINASE INHIBITOR (CGP-57148)
Authors: BERAN M CAO X ESTROV Z JEHA S JIN G OBRIEN S TALPAZ M ARLINGHAUS RB LYDON MB KANTARJIAN H
Citation: M. Beran et al., SELECTIVE-INHIBITION OF CELL-PROLIFERATION AND BCR-ABL PHOSPHORYLATION IN ACUTE LYMPHOBLASTIC-LEUKEMIA CELLS EXPRESSING 190-KD BCR-ABL PROTEIN BY A TYROSINE KINASE INHIBITOR (CGP-57148), Blood, 90(10), 1997, pp. 1090-1090
ACUTE LYMPHOBLASTIC LEUKEMIAS FROM RELAPSE ENGRAFT MORE RAPIDLY IN SCID MICE
Authors: PALUCKA AK SCUDERI R PORWIT A JEHA S GRUBER A BJORKHOLM M BERAN M PISA P
Citation: Ak. Palucka et al., ACUTE LYMPHOBLASTIC LEUKEMIAS FROM RELAPSE ENGRAFT MORE RAPIDLY IN SCID MICE, Leukemia, 10(3), 1996, pp. 558-563
ENGRAFTMENT OF CHRONIC PROLYMPHOCYTIC AND T-CELL LEUKEMIA IN SCID MICE
Authors: OBRIEN S JEHA S KANTARJIAN H PISA P JIN G KEATING M BERAN M
Citation: S. Obrien et al., ENGRAFTMENT OF CHRONIC PROLYMPHOCYTIC AND T-CELL LEUKEMIA IN SCID MICE, Leukemia, 10(2), 1996, pp. 338-344
ANTISENSE RNA INHIBITION OF PHOSPHOPROTEIN P18 EXPRESSION ABROGATES THE TRANSFORMED PHENOTYPE OF LEUKEMIC-CELLS
Authors: JEHA S LUO XN BERAN M KANTARJIAN H ATWEH GF
Citation: S. Jeha et al., ANTISENSE RNA INHIBITION OF PHOSPHOPROTEIN P18 EXPRESSION ABROGATES THE TRANSFORMED PHENOTYPE OF LEUKEMIC-CELLS, Cancer research, 56(6), 1996, pp. 1445-1450
TALLIMUSTINE, AN EFFECTIVE ANTILEUKEMIC AGENT IN A SCID MOUSE MODEL OF ADULT MYELOGENOUS LEUKEMIA (AML), INDUCES REMISSIONS IN A PHASE STUDY
Authors: BERAN M JEHA S OBRIEN S ESTEY E VITEK L ZURLO M RIOS MB KEATING M KANTARJIAN H
Citation: M. Beran et al., TALLIMUSTINE, AN EFFECTIVE ANTILEUKEMIC AGENT IN A SCID MOUSE MODEL OF ADULT MYELOGENOUS LEUKEMIA (AML), INDUCES REMISSIONS IN A PHASE STUDY, Blood, 88(10), 1996, pp. 868-868
GROWTH AND BIOLOGIC PROPERTIES OF KARYOTYPICALLY DEFINED SUBCATEGORIES OF ADULT ACUTE LYMPHOCYTIC-LEUKEMIA IN MICE WITH SEVERE COMBINED IMMUNODEFICIENCY
Authors: JEHA S KANTARJIAN H OBRIEN S HUH Y PISA P ORDONEZ N BERAN M
Citation: S. Jeha et al., GROWTH AND BIOLOGIC PROPERTIES OF KARYOTYPICALLY DEFINED SUBCATEGORIES OF ADULT ACUTE LYMPHOCYTIC-LEUKEMIA IN MICE WITH SEVERE COMBINED IMMUNODEFICIENCY, Blood, 86(11), 1995, pp. 4278-4285
EFFECTS OF PIXY321 (GM-CSF IL-3 FUSION PROTEIN) IN PATIENTS (PTS) WITH MYELODYSPLASTIC SYNDROMES (MDS)/
Authors: VADHANRAJ S BROXMEYER HE JEHA S ESTEY E ANDREEFF M THOMPSON P TRAHANRIEGER P GARRISON L
Citation: S. Vadhanraj et al., EFFECTS OF PIXY321 (GM-CSF IL-3 FUSION PROTEIN) IN PATIENTS (PTS) WITH MYELODYSPLASTIC SYNDROMES (MDS)/, Blood, 86(10), 1995, pp. 1336-1336
HIGH-DOSE MERCAPTOPURINE FOLLOWED BY INTERMEDIATE-DOSE CYTARABINE IN RELAPSED ACUTE-LEUKEMIA
Authors: LOCKHART S PLUNKETT W JEHA S RAMIREZ I ZIPF T CORK A PINKEL D
Citation: S. Lockhart et al., HIGH-DOSE MERCAPTOPURINE FOLLOWED BY INTERMEDIATE-DOSE CYTARABINE IN RELAPSED ACUTE-LEUKEMIA, Journal of clinical oncology, 12(3), 1994, pp. 587-595
EFFECTS OF THE FUSION PROTEIN PIXY321 ON THE PROLIFERATION OF BONE-MARROW CELLS IN PATIENTS WITH DIAMOND-BLACKFAN ANEMIA
Authors: MOORE DF ANDREEFF M MAHADEVIA R VAN N ZHAO S GOODACRE A JEHA S VADHANRAJ S
Citation: Df. Moore et al., EFFECTS OF THE FUSION PROTEIN PIXY321 ON THE PROLIFERATION OF BONE-MARROW CELLS IN PATIENTS WITH DIAMOND-BLACKFAN ANEMIA, Blood, 82(10), 1993, pp. 10000089-10000089
GROWTH OF KARYOTYPICALLY DEFINED SUBCATEGORIES OF AML CELLS FROM UNTREATED PATIENTS IN SCID MICE
Authors: JEHA S OBRIEN S KANTARJIAN M ORDONEZ NG PISA P TALPAZ M BERAN M
Citation: S. Jeha et al., GROWTH OF KARYOTYPICALLY DEFINED SUBCATEGORIES OF AML CELLS FROM UNTREATED PATIENTS IN SCID MICE, Blood, 82(10), 1993, pp. 10000123-10000123
STIMULATION OF HEMATOPOIESIS BY PIXY321 (GM-CSF IL-3 FUSION PROTEIN) IN PATIENTS WITH BONE-MARROW FAILURE/
Authors: VADHANRAJ S JEHA S BROXMEYER HE HITTELMAN WN THOMPSON P ARCENAS A HOOTS WK ESTEY E GARRISON L
Citation: S. Vadhanraj et al., STIMULATION OF HEMATOPOIESIS BY PIXY321 (GM-CSF IL-3 FUSION PROTEIN) IN PATIENTS WITH BONE-MARROW FAILURE/, Blood, 82(10), 1993, pp. 10000366-10000366
THE SUITABILITY OF THE SCID MOUSE MODEL OF HUMAN ACUTE MYELOGENOUS LEUKEMIA FOR EVALUATION OF ACTIVITY OF NEW ANTILEUKEMIA AGENTS
Authors: BERAN M JEHA S OBRIEN S PISA P KANTARJIAN M
Citation: M. Beran et al., THE SUITABILITY OF THE SCID MOUSE MODEL OF HUMAN ACUTE MYELOGENOUS LEUKEMIA FOR EVALUATION OF ACTIVITY OF NEW ANTILEUKEMIA AGENTS, Blood, 82(10), 1993, pp. 10000535-10000535
GROWTH OF PRIMARY HUMAN ACUTE LYMPHOCYTIC-LEUKEMIA IN SEVERE COMBINEDIMMUNODEFICIENT MICE
Authors: JEHA S KANTARJIAN H OBRIEN S HUH Y PISA P STEPHENS L ORDONEZ N BERAN M
Citation: S. Jeha et al., GROWTH OF PRIMARY HUMAN ACUTE LYMPHOCYTIC-LEUKEMIA IN SEVERE COMBINEDIMMUNODEFICIENT MICE, Blood, 82(10), 1993, pp. 10000540-10000540
Risultati: 1-17 |